These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6549185)

  • 1. Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide.
    Crider AM; Hemdi TF; Hassan MN; Fahn S
    J Pharm Sci; 1984 Nov; 73(11):1585-7. PubMed ID: 6549185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
    Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
    Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
    Hassan MN; Higgins D; Traub M; Fahn S
    Life Sci; 1986 Aug; 39(6):513-8. PubMed ID: 3090394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of aromatic dihydroxylated spiro[indan-1,3'-pyrrolidine] and spiro[indan-2,2'-pyrrolidine] derivatives.
    Sommerville R; Rosenberg HE; Crooks PA
    J Pharm Sci; 1985 May; 74(5):553-5. PubMed ID: 4020632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.
    Harrold MW; Wallace RA; Farooqui T; Wallace LJ; Uretsky N; Miller DD
    J Med Chem; 1989 Apr; 32(4):874-80. PubMed ID: 2522993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.
    Hacksell U; Arvidsson LE; Svensson U; Nilsson JL; Sanchez D; Wikström H; Lindberg P; Hjorth S; Carlsson A
    J Med Chem; 1981 Dec; 24(12):1475-82. PubMed ID: 6796690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
    Satoh H; Satoh Y; Notsu Y; Honda F
    Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic receptors are not essential for dopaminergic feedback regulation.
    Di Chiara G; Porceddu ML; Fratta W; Gessa GL
    Nature; 1977 May; 267(5608):270-2. PubMed ID: 865621
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912.
    Coward DM; Dixon AK; Urwyler S; White TG; Enz A; Karobath M; Shearman G
    J Pharmacol Exp Ther; 1990 Jan; 252(1):279-85. PubMed ID: 1967646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones.
    Olianas MC; De Montis GM; Concu A; Tagliamonte A; di Chiara G
    Eur J Pharmacol; 1978 Jun; 49(3):223-32. PubMed ID: 566206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities.
    Florvall L; Ogren SO
    J Med Chem; 1982 Nov; 25(11):1280-6. PubMed ID: 6128419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
    Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
    Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisuride and transdihydrolisuride: differences in action on central dopaminergic functions in dependence on the location and the state of receptors.
    Krejci I; Schuh J; Prágerová H; Dlabac A
    Pol J Pharmacol Pharm; 1985; 37(3):263-71. PubMed ID: 4070078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.